Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (NHPAP) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for National Healthcare Properties (NHPAP) over the last 13 years, with Q3 2025 value amounting to -$634000.0.

  • National Healthcare Properties' Net Cash Flow fell 11609.55% to -$634000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year increase of 37649.83%. This contributed to the annual value of -$17.2 million for FY2024, which is 21653.13% down from last year.
  • According to the latest figures from Q3 2025, National Healthcare Properties' Net Cash Flow is -$634000.0, which was down 11609.55% from -$23.2 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare Properties' Net Cash Flow registered a high of $52.3 million during Q1 2025, and its lowest value of -$23.4 million during Q2 2022.
  • Moreover, its 5-year median value for Net Cash Flow was -$634000.0 (2025), whereas its average is $641578.9.
  • As far as peak fluctuations go, National Healthcare Properties' Net Cash Flow tumbled by 3615666.67% in 2024, and later surged by 45104.68% in 2025.
  • Quarter analysis of 5 years shows National Healthcare Properties' Net Cash Flow stood at $29.5 million in 2021, then crashed by 57.45% to $12.6 million in 2022, then tumbled by 99.76% to $30000.0 in 2023, then tumbled by 36156.67% to -$10.8 million in 2024, then soared by 94.14% to -$634000.0 in 2025.
  • Its Net Cash Flow was -$634000.0 in Q3 2025, compared to -$23.2 million in Q2 2025 and $52.3 million in Q1 2025.